Minerva Neurosciences Inc Capital Reinvestment Ratio

Latest as of December 2017: 0.02x

Minerva Neurosciences Inc capital reinvestment ratio. Minerva Neurosciences Inc (NERV) has a Capital Reinvestment Ratio of 0.02x as of December 2017, meaning it reinvests 0% of its operating cash flow ($3.09 Million) in capital expenditures ($52.40K). Check Minerva Neurosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

$3.09 Million
USD

Capital Expenditures

$52.40K
USD

Data as of

Dec 2017
Most recent filing

Capital Reinvestment Ratio of Minerva Neurosciences Inc (2017–2017)

Capital reinvestment ratio of Minerva Neurosciences Inc from 2017 to 2017. This chart tracks Minerva Neurosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore NERV year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Minerva Neurosciences Inc Capital Reinvestment Ratio by Year (2017–2017)

Minerva Neurosciences Inc capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see Minerva Neurosciences Inc (NERV) cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2017 0.02x $3.09 Million $52.40K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow